Your daily source for trading strategies, tech news, and politically incorrect humor.
Hey there, Bullets Fans –
Your Morning Bullets Brief Updates are here!
Did you know that on this day back in 1848, the Gold Rush of 1849 was triggered when a US President confirmed that gold had been found in California.
Who was the President responsible for starting the Gold Rush?
Think you know the answer? You can check it in the closing area down below!
Image Source: Getty Images
Imagine if you could get paid $1,500 to receive a virus vaccine. One $380 billion proposal seeks to make that a reality.
“We have to create, in my judgment, an incentive for people to really accelerate their thinking about taking the vaccine,” said John Delaney, the entrepreneur behind the idea. “If you’re still afraid of the vaccine and don’t want to take it, that’s your right. You won’t participate in this program. But guess what? You’re going to benefit anyhow, because we’ll get the country to herd immunity faster, which benefits you. So I think everyone wins.”
However, not everyone is as enthusiastic about the idea.
“It’s always nice to be able to kill two birds with one stone, but in this case I think the two birds are flying off in different directions,” said Urban-Brookings Tax Policy Center Senior Fellow Howard Gleckman. “It’s going to be really hard to make it work.”
Other Top Financial News
This “Big Switch” is coming – and you’d better be ready for it
Image Source: NYSE
Investor attention next week will be split between fiscal stimulus and vaccine news.
On the stimulus package front, the forward momentum could carry into next week.
“It probably boils down to how much [Senate Majority Leader] Mitch McConnell is willing to deal, and I don’t know what the answer is to that,” said Mike Schumacher of Wells Fargo. “If it’s going to happen, next week is the week. The government runs out of money on Friday. Congress has to come up with a funding scheme.”
At the same time, investors are keeping their eyes on developments on the vaccine front, as the FDA discusses whether to grant emergency use authorization for the Pfizer solution on Thursday.
“They’re starting to roll it out in the U.K., and that’s something that’s going to be watched here to see how it unfolds. That’s the next issue for the market,” said Prudential Financial strategist Quincy Krosby.
Market Movers & Predictions